These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8463731)

  • 1. Identification of high intraocular pressure responders to topical ophthalmic corticosteroids.
    Bartlett JD; Woolley TW; Adams CM
    J Ocul Pharmacol; 1993; 9(1):35-45. PubMed ID: 8463731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular-hypertensive response to topical steroids in children.
    Kwok AK; Lam DS; Ng JS; Fan DS; Chew SJ; Tso MO
    Ophthalmology; 1997 Dec; 104(12):2112-6. PubMed ID: 9400772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.
    Schachar RA; Raber S; Courtney R; Zhang M
    Curr Eye Res; 2011 Sep; 36(9):809-17. PubMed ID: 21851167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
    Weinreb RN; Scassellati Sforzolini B; Vittitow J; Liebmann J
    Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertension.
    Franks W;
    Curr Med Res Opin; 2006 Sep; 22(9):1643-9. PubMed ID: 16968567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular pressure response to loteprednol etabonate in known steroid responders.
    Bartlett JD; Horwitz B; Laibovitz R; Howes JF
    J Ocul Pharmacol; 1993; 9(2):157-65. PubMed ID: 8345288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of steroid induced-ocular hypertension in postoperative pterygium excision.
    Makornwattana M; Suphachearaphan W
    J Med Assoc Thai; 2015 Mar; 98 Suppl 2():S151-7. PubMed ID: 26211117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid-induced ocular hypertension in normal cattle.
    Gerometta R; Podos SM; Candia OA; Wu B; Malgor LA; Mittag T; Danias J
    Arch Ophthalmol; 2004 Oct; 122(10):1492-7. PubMed ID: 15477461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension.
    Narayanaswamy A; Neog A; Baskaran M; George R; Lingam V; Desai C; Rajadhyaksha V
    Indian J Ophthalmol; 2007; 55(2):127-31. PubMed ID: 17322603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.
    Diestelhorst M
    Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):433-9. PubMed ID: 10901475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
    Sheppard JD; Comstock TL; Cavet ME
    Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study.
    Berlin MS; Rowe-Rendleman C; Ahmed I; Ross DT; Fujii A; Ouchi T; Quach C; Wood A; Ward CL
    Br J Ophthalmol; 2016 Jun; 100(6):843-7. PubMed ID: 26453641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
    Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
    PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized parallel group study of 0.0015% tafluprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension (comparison with 0.005% latanoprost ophthalmic solution)].
    Ge J; Li X; Sun X; He X; Zhang H
    Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):95-102. PubMed ID: 25907999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of corticosteroid-induced intraocular pressure elevation using ISV-205.
    Stewart WC;
    Arch Ophthalmol; 2003 Nov; 121(11):1543-7. PubMed ID: 14609909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of unoprostone isopropyl 0.12% and timolol maleate 0.5% on diurnal intraocular pressure.
    Stewart WC; Stewart JA; Kapik BM
    J Glaucoma; 1998 Dec; 7(6):388-94. PubMed ID: 9871860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication.
    King AJ; Rotchford AP
    JAMA Ophthalmol; 2016 Jul; 134(7):742-7. PubMed ID: 27148831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of ocular hypertension in children treated with systemic glucocorticoid.
    Krag S; Larsen D; Albertsen BK; Glerup M
    Acta Ophthalmol; 2021 Dec; 99(8):e1430-e1434. PubMed ID: 33629533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study.
    Brandt JD; Sall K; DuBiner H; Benza R; Alster Y; Walker G; Semba CP;
    Ophthalmology; 2016 Aug; 123(8):1685-1694. PubMed ID: 27157843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma.
    Ishibashi S; Hirose N; Tawara A; Kubota T
    J Glaucoma; 2006 Oct; 15(5):354-7. PubMed ID: 16988595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.